Mohammed Abed Jawad
Overview
Explore the profile of Mohammed Abed Jawad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jasim S, Farhan S, Ahmad I, Hjazi A, Kumar A, Abed Jawad M, et al.
Funct Integr Genomics
. 2025 Jan;
25(1):6.
PMID: 39753912
This detailed study examines the complex role of the SOX family in various tumorigenic contexts, offering insights into how these transcription factors function in cancer. As the study progresses, it...
2.
Hsu C, Jamal A, Kamal M, Ahmad F, Olegovich Bokov D, Mustafa Y, et al.
Gene
. 2024 Dec;
940():149180.
PMID: 39708931
Liver cancer ranks as the sixth most prevalent form of cancer and stands as the fourth leading cause of cancer-related fatalities on a global scale. The two primary types of...
3.
Hsu C, Pallathadka H, Jasim S, Rizaev J, Olegovich Bokov D, Hjazi A, et al.
Crit Rev Oncol Hematol
. 2024 Dec;
206:104588.
PMID: 39667718
A major advance in cancer treatment has been the development and refinement of cancer immunotherapy. The discovery of immunotherapies for a wide range of cancers has revolutionized cancer treatment paradigms....
4.
Exosomal noncoding RNA (ncRNA) in breast cancer pathogenesis and therapy; two sides of the same coin
Ibrahim F, Saleh R, Uinarni H, Olegovich Bokov D, Menon S, Zarifovich K, et al.
Exp Cell Res
. 2024 Nov;
444(1):114359.
PMID: 39608481
Over the past few years, breast cancer has become the most prevalent type of cancer globally, with the primary cause of death from the disease being metastatic cancer. This has...
5.
Rodrigues P, Rizaev J, Hjazi A, Altalbawy F, H M, Sharma K, et al.
Exp Cell Res
. 2024 Sep;
442(2):114236.
PMID: 39245198
Widespread changes in the expression of microRNAs in cancer result in abnormal gene expression for the miRNAs that control those genes, which in turn causes changes to entire molecular networks...
6.
Jasim S, Farhan S, Ahmad I, Hjazi A, Kumar A, Abed Jawad M, et al.
Mol Biol Rep
. 2024 Sep;
51(1):964.
PMID: 39240390
The intricate interplay between Homeobox genes, long non-coding RNAs (lncRNAs), and the development of malignancies represents a rapidly expanding area of research. Specific discernible lncRNAs have been discovered to adeptly...
7.
Farhan S, Jasim S, Bansal P, Kaur H, Abed Jawad M, Qasim M, et al.
Cell Biochem Biophys
. 2024 Sep;
82(4):3091-3108.
PMID: 39225902
Inflammation and autoimmune diseases (AD) are common outcomes of an overactive immune system. Inflammation occurs due to the immune system reacting to damaging stimuli. Exosomes are being recognized as an...
8.
Al-Hawary S, Altalbawy F, Jasim S, S R, Jamal A, Naiyer M, et al.
Cell Biol Int
. 2024 Aug;
48(11):1601-1611.
PMID: 39164963
This study explores the critical role of inhibitors targeting the mammalian target of rapamycin (mTOR) signaling pathway in breast cancer research and treatment. The mTOR pathway, a central regulator of...
9.
Pallathadka H, Khaleel A, Zwamel A, Malathi H, Sharma S, Rizaev J, et al.
Cell Biochem Biophys
. 2024 Aug;
82(4):3015-3030.
PMID: 39110298
Toll-like receptors (TLRs) are essential receptors involved in inflammation and innate immunity. Various types of cancer cells, as well as innate immune cells, express TLRs. There is mounting proof that...
10.
Pallathadka H, Hsu C, Saleh R, Jyothi S, Kumar A, Yumashev A, et al.
Int Immunopharmacol
. 2024 Jul;
140:112730.
PMID: 39083927
Colorectal cancer (CRC) involves various genetic alterations, with liver metastasis posing a significant clinical challenge. Furthermore, CRC cells mostly show an increase in resistance to traditional treatments like chemotherapy. It...